Alloferon-Zn is a new substance developed by our research team through protenomics technology for peptide application, which technology has been developed through years of research. Its international patent application has been registered, and preparations for multi-national clinical trials are in progress. Alloferon-Zn is a new substance that induces the
vitalization of the human body’s immune system by bonding with various essential minerals required for physiological activation in the body, while retaining the general properties of Alloferon.
Fundamental studies on Alloferon-Zn have been completed for treatment of Asthma, Atopic dermatitis, and allergies,
for which there is no effective treatment in the current market. Preparations for preclinical studies and clinical trials are
in progress for new drug registration in Europe.